Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Nonadherence, Medication: early-phase trial registry

A small indexed set (3 trials) with no open enrollment listed right now.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · none currently recruiting · #5,209 of 28,707 conditions by registered trial count

Nonadherence, Medication: 3 US clinical trials tracked, none currently recruiting.

Nonadherence, Medication is the subject of 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Washington University School of Medicine, running 2 of these trials.

Enrollment posture brief

Registry condition nonadherence-medication

OPEN 0 | RECR 0% | LATE 0 | EARLY 2 | RANK #5209 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Nonadherence, Medication (th…0%
Open-enrollment share among volume-matched conditions near Nonadherence, Medication

Nonadherence, Medication has no open enrollment in this registry pull (3 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Nonadherence, Medication on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Nonadherence, Medication is recruiting below its size-band peers.

    0 of 3 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 12

Phase Distribution

PhaseTrial count
Phase 1 2

Named interventions

Most-linked intervention names on Nonadherence, Medication records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA Drug
1 trials
Self-Monitoring Behavioral
1 trials
iTAB-CV Behavioral
1 trials
Symptom-driven budesonide/formoterol combination Drug
1 trials
Maintenance ICS and Symptom Driven SABA Drug
1 trials

US sites by state

Facility locations filed on Nonadherence, Medication trials. A trial with sites in several states counts in each.

Missouri 2 trials
Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Nonadherence, Medication page

3 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nonadherence, Medication condition card totals 3 registered trials; most-linked intervention Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA; top US site state Missouri. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.